semaglutide advisory committee Wegovy (semaglutide) is a step closer to being subsidised in Australia, after the Pharmaceutical Benefits (PBAC) recommended it be listed on the PBS for some adults living with obesity and FDA Proposes to Exclude Ozempic,

The 0.25 mg is building the foundation for higher doses

For patients also dealing with fatigue or hormonal imbalances, we offer integrated testosterone therapy and hormone replacement therapy programs that complement GLP-1 treatment

Farmers should focus on leaner yields

An international trial of antioxidants in the prevention of preeclampsia (INTAPP)

Each component carries its own literature BPC-157 in tissue-repair and gastrointestinal models, TB-500 (thymosin 4 fragment) in angiogenesis and cell-migration models, GHK-Cu in collagen and skin-remodeling work, and KPV as an anti-inflammatory tripeptide

PlexusDx genetic testing analyzes GLP1R, GIPR, FTO, and MC4R variants that influence how your body responds to semaglutide and other GLP-1 therapies